ArticleJournal of medicinal chemistry2022

Potent Ruthenium-Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to

Manikandan M et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.